Another mRNA-based vaccine candidate protects animals against SARS-CoV-2

(Cell Press) An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice and non-human primates, researchers report on July 23rd in the journal Cell. Two injections of the vaccine were sufficient to induce robust immunity, completely preventing SARS-CoV-2 infection in mice.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news